We have previously demonstrated that prostate‐specific heterozygous loss of Spry2 does not result in tumour formation, while the heterozygous loss of Pten alone causes PIN (prostatic intraepithelial neoplasia) lesions (Gao et al, 2012; Patel et al, 2013). This evidence concerns the gene SPRY2 and neoplasm.